Navion Neurosciences has successfully closed a $10.8 million Seed financing round. The capital will be used to advance their precision sodium-channel medicines aimed at treating epilepsy and neuropathic pain. This funding will support their research and development efforts. The round demonstrates strong investor confidence in Navion's innovative approach.
Company Information
Company
Navion Neurosciences
Location
Charlottesville, Virginia, United States
About
Navion Neurosciences is focused on developing precision sodium-channel medicines to treat epilepsy and neuropathic pain. The company aims to advance innovative therapies that cater specifically to the needs of patients with these conditions. Their mission is to improve patient outcomes through targeted neurological treatments.
Don't miss Navion Neurosciences's next move
Get an email the moment Navion Neurosciences raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Navion Neurosciences's next move
CharlottesvilleBiotechnologyHealth CareMedicalTherapeutics